Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results serologic response (seroconversion) ST cell response S

COVID-19 prophylaxis (excluding children) meta-analysis

Boyarsky DESCvaccinesuncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results 17.4%
Boyarsky DESCmRNA vaccineuncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results 14.9%

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).